ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Gujarat Themis Biosyn issued a corrigendum to its 45th AGM notice, updating the preferential issue resolution regarding share price, issue size, and allottee details.
Gujarat Themis Biosyn Limited acquired MicroBiopharm Japan Co. Ltd. for approximately ₹1,300 Crore. This acquisition expands its pharmaceutical CDMO capabilities.
Gujarat Themis Biosyn Limited has fixed September 23, 2026, as the record date for determining member entitlement for the final dividend for FY 2025-26.
GTBL completed 100% acquisition of MBJ Japan for JPY 21.5 billion (~₹1,333 Cr). The deal adds three GMP plants and precision fermentation capabilities.
Gujarat Themis Biosyn Limited announced the allotment of non-convertible debt securities. The filing serves as a regulatory disclosure regarding the issuance of these instruments.
Gujarat Themis Biosyn Ltd has submitted its quarterly shareholding pattern. This filing is a routine disclosure mandated by SEBI regulations.
The board of Gujarat Themis Biosyn approved the issuance of Non-Convertible Debentures (NCDs) aggregating up to ₹585 Crore on a private placement basis.
Gujarat Themis Biosyn Ltd has scheduled a board meeting for September 10, 2026, to consider raising funds through the private placement of non-convertible debentures.
Gujarat Themis Biosyn Limited has filed its Integrated Annual Report for the FY 2025-26 in compliance with SEBI LODR regulations.
Gujarat Themis Biosyn Limited issued a notice for its 45th Annual General Meeting scheduled for September 30, 2026, to transact various ordinary and special business items.